192 related articles for article (PubMed ID: 33004948)
21. Patchouli oil ameliorates 5-fluorouracil-induced intestinal mucositis in rats via protecting intestinal barrier and regulating water transport.
Gan Y; Ai G; Wu J; Luo H; Chen L; Huang Q; Wu X; Xu N; Li M; Su Z; Liu Y; Huang X
J Ethnopharmacol; 2020 Mar; 250():112519. PubMed ID: 31883475
[TBL] [Abstract][Full Text] [Related]
22. Oral Colonisation after the Administration of Drops Containing Lactobacillus reuteri.
Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
Oral Health Prev Dent; 2020 Nov; 18():1017-1023. PubMed ID: 33215493
[TBL] [Abstract][Full Text] [Related]
23. Treatment with selenium-enriched Saccharomyces cerevisiae UFMG A-905 partially ameliorates mucositis induced by 5-fluorouracil in mice.
Porto BAA; Monteiro CF; Souza ÉLS; Leocádio PCL; Alvarez-Leite JI; Generoso SV; Cardoso VN; Almeida-Leite CM; Santos DA; Santos JRA; Nicoli JR; Pessione E; Martins FS
Cancer Chemother Pharmacol; 2019 Jul; 84(1):117-126. PubMed ID: 31079219
[TBL] [Abstract][Full Text] [Related]
24. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
[TBL] [Abstract][Full Text] [Related]
25. Heat-killed Limosilactobacillus reuteri ATCC PTA 6475 prevents bone loss in ovariectomized mice: A preliminary study.
Ribeiro JL; Santos TA; Garcia MT; Carvalho BFDC; Esteves JECS; Moraes RM; Anbinder AL
PLoS One; 2024; 19(5):e0304358. PubMed ID: 38820403
[TBL] [Abstract][Full Text] [Related]
26. An enhanced Lactobacillus reuteri biofilm formulation that increases protection against experimental necrotizing enterocolitis.
Olson JK; Navarro JB; Allen JM; McCulloh CJ; Mashburn-Warren L; Wang Y; Varaljay VA; Bailey MT; Goodman SD; Besner GE
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G408-G419. PubMed ID: 29848024
[TBL] [Abstract][Full Text] [Related]
27. The use of
Borrell García C; Ribelles Llop M; García Esparza MÁ; Flichy-Fernández AJ; Marqués Martínez L; Izquierdo Fort R
Int J Immunopathol Pharmacol; 2021; 35():20587384211031107. PubMed ID: 34325540
[TBL] [Abstract][Full Text] [Related]
28. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Spinler JK; Taweechotipatr M; Rognerud CL; Ou CN; Tumwasorn S; Versalovic J
Anaerobe; 2008 Jun; 14(3):166-71. PubMed ID: 18396068
[TBL] [Abstract][Full Text] [Related]
29. Probiotic therapy reduces inflammation and improves intestinal morphology in rats with induced oral mucositis.
Gerhard D; Sousa FJDSS; Andraus RAC; Pardo PE; Nai GA; Neto HB; Messora MR; Maia LP
Braz Oral Res; 2017 Jul; 31():e71. PubMed ID: 28678976
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of dexamethasone on 5-FU-induced oral mucositis in hamsters.
Ribeiro SB; de Araújo AA; Araújo Júnior RF; Brito GAC; Leitão RC; Barbosa MM; Garcia VB; Medeiros AC; Medeiros CACX
PLoS One; 2017; 12(10):e0186511. PubMed ID: 29059216
[TBL] [Abstract][Full Text] [Related]
31. Probiotic Lactobacillus reuteri strains ATCC PTA 5289 and ATCC 55730 differ in their cariogenic properties in vitro.
Jalasvuori H; Haukioja A; Tenovuo J
Arch Oral Biol; 2012 Dec; 57(12):1633-8. PubMed ID: 23010217
[TBL] [Abstract][Full Text] [Related]
32. Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice.
Ahl D; Liu H; Schreiber O; Roos S; Phillipson M; Holm L
Acta Physiol (Oxf); 2016 Aug; 217(4):300-10. PubMed ID: 27096537
[TBL] [Abstract][Full Text] [Related]
33. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the mucoprotective effects of glycyrrhizic acid-loaded polymeric nanoparticles in a murine model of 5-fluorouracil-induced intestinal mucositis via suppression of inflammatory mediators and oxidative stress.
Zeeshan M; Atiq A; Ain QU; Ali J; Khan S; Ali H
Inflammopharmacology; 2021 Oct; 29(5):1539-1553. PubMed ID: 34420176
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children.
Szajewska H; Urbańska M; Chmielewska A; Weizman Z; Shamir R
Benef Microbes; 2014 Sep; 5(3):285-93. PubMed ID: 24463209
[TBL] [Abstract][Full Text] [Related]
36. Lactobacillus reuteri effects on maternal separation stress in newborn mice.
Park ES; Freeborn J; Venna VR; Roos S; Rhoads JM; Liu Y
Pediatr Res; 2021 Nov; 90(5):980-988. PubMed ID: 33531679
[TBL] [Abstract][Full Text] [Related]
37. Effects of long-term administration of Lactobacillus reuteri DSM-17938 on circulating levels of 5-HT and BDNF in adults with functional constipation.
Riezzo G; Chimienti G; Orlando A; D'Attoma B; Clemente C; Russo F
Benef Microbes; 2019 Mar; 10(2):137-147. PubMed ID: 30574801
[TBL] [Abstract][Full Text] [Related]
38. Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster.
Leitão RF; Ribeiro RA; Lira AM; Silva LR; Bellaguarda EA; Macedo FD; Sousa RB; Brito GA
Cancer Chemother Pharmacol; 2008 Feb; 61(2):215-22. PubMed ID: 17426972
[TBL] [Abstract][Full Text] [Related]
39. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
[TBL] [Abstract][Full Text] [Related]
40. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
